整合QSAR建模与强化学习用于Syk抑制剂发现
Maria Zavadskaya1, Anastasia Orlova1, Andrei Dmitrenko2
1Center for AI in Chemistry, ITMO University, Lomonosova St. 9, St. Petersburg, 197101, Russia.
Journal of cheminformatics
|April 15, 2025
概括
研究人员开发了一种新的深度强化学习策略,以发现用于自身免疫性疾病的新腺氨酸激酶 (Syk) 抑制剂. 这种方法确定了139种具有高强度和结构新性的有前途的候选药物.
科学领域:
- 药用化学 医学化学
- 计算机化药物发现技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 腺氨酸激酶 (Syk) 是炎症途径的关键调解物,也是免疫性血栓塞缩症等自身免疫性疾病的治疗点.
- 现有的Syk抑制剂表现出低于最佳的疗效和安全性,推动了对新药发现方法的需求.
研究的目的:
- 开发和应用一种新的深度强化学习策略,用于识别新的腺氨酸激酶 (Syk) 抑制剂.
- 产生结构新的Syk抑制剂,具有高预测强度和有利的类似药物的特性.
主要方法:
- 整合定量结构-活动关系 (QSAR) 预测与使用堆叠整体方法的生成建模.
- 产生和选超过78,000个分子,以确定有希望的Syk抑制剂候选者.
- 根据预测的效能,结合亲和力和药物相似性来评估候选药物.
主要成果:
- 一个深度强化学习模型在预测分子活动时实现了0.78的相关系数.
- 确定了139个具有高预测功效,结合亲和力和药物相似性的候选分子.
- 这些已识别的化合物在保持关键的Syk抑制剂特征的同时表现出结构上的新性.
结论:
- 开发的QSAR引导强化学习框架加速了新型Syk抑制剂的发现.
- 这种方法为药物发现提供了一种多功能方法,特别是在罕见疾病治疗方面.
- 这项研究为Syk抑制剂发现提供了QSAR引导强化学习的首次应用,产生了有前途的新型候选者.
更多相关视频
00:05In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
13.8K
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
469
相关概念视频
Structure-Activity Relationships and Drug Design
450
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
450
Drug Discovery: Overview
7.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.2K
Ligand Binding Sites
12.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K
